SYSTEMIC LUPUS ERYTHEMATOSUS: RECENT ADVANCES IN ITS DIAGNOSIS AND TREATMENT
Authors: E L DUBOIS
Journal: Annals of Internal Medicine (1956)

Article1 August 1956SYSTEMIC LUPUS ERYTHEMATOSUS: RECENT ADVANCES IN ITS DIAGNOSIS AND TREATMENTEDMUND L. DUBOIS, M.D., F.A.C.P.EDMUND L. DUBOIS, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-45-2-163 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDuring the last six years the author has had the opportunity personally to study and treat 175 patients with systemic lupus erythematosus. The purpose of this paper is to review the current status (to January, 1956) of 163 of these patients, who have adequate records available, in order to determine the following:1. The incidence of the disease in a 3,600 bed hospital before and after the frequent use of the L.E. cell test.2. The course of the disease with particular reference to spontaneous remissions.3. The value of a battery of different types of L.E. cell tests.4....Bibliography1. HargravesRichmondMorton MMHR: Presentation of two bone marrow elements: the "tart" cell and the "L.E." cell, Proc. Staff Meet., Mayo Clin. 23: 25, 1948. MedlineGoogle Scholar2. Dubois EL: Simplified method for the L.E. cell test, Arch. Int. Med. 92: 168, 1953. CrossrefGoogle Scholar3. Dubois EL: The effect of the L.E. cell test on the clinical picture of systemic lupus erythematosus, Ann. Int. Med. 38: 1265, 1953. LinkGoogle Scholar4. HarveyShulmanTumultyConleySchoenrich AMLEPACLEH: Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases, Medicine 33: 291, 1954. CrossrefMedlineGoogle Scholar5. MerrellShulman MLE: Determination of prognosis in chronic disease illustrated by systemic lupus erythematosus, J. Chron. Dis. 1: 12, 1955. CrossrefMedlineGoogle Scholar6. MooreLutz JEWB: The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors, J. Chron. Dis. 1: 297, 1955. CrossrefMedlineGoogle Scholar7. Dubois EL: Discoid lupus erythematosus: an analysis of its systemic manifestations, Ann. Int. Med. 44: 482-496 (Mar.) 1956. LinkGoogle Scholar8. Ben-Asher S: Recurrent acute lupus erythematosus disseminatus: report of a case which has survived 23 years after the onset of systemic manifestations, Ann. Int. Med. 34: 243, 1951. LinkGoogle Scholar9. WeissSwift RSS: The significance of a positive L.E. phenomenon, Arch. Dermat. and Syph. 72: 103, 1955. CrossrefGoogle Scholar10. ZimmerHargraves FEMM: The effect of blood coagulation on L.E. cell formation, Proc. Staff Meet., Mayo Clin. 27: 424, 1952. MedlineGoogle Scholar11. SnapperNathan IDJ: The mechanics of the L.E. cell phenomenon, studied with a simplified test, Blood 10: 718, 1955. CrossrefMedlineGoogle Scholar12. Prokoptchouk AJ: Traitement du lupus erythemateus par l'acriquine, Vestnik. venerol. dermat. 2/3: 23, 1940. Abstracted, Yearbook of Dermatology and Syphilology, 1952, edited by M. B. Sulzberger and R. L. Baer, Chicago. Year Book Publishers, Inc., 1953, p. 92. Google Scholar13. Page F: Treatment of lupus erythematosus with Mepacrine, Lancet 2: 755, 1951. CrossrefMedlineGoogle Scholar14. Dubois EL: Quinacrine (Atabrine) in treatment of systemic and discoid lupus erythematosus, Arch. Int. Med. 94: 131, 1954. CrossrefGoogle Scholar15. LeeperAllende RWMF: Antimalarials in the treatment of discoid lupus erythematosus, Arch. Dermat. and Syph. 73: 50, 1956. CrossrefGoogle Scholar16. DuboisCommonsStarrSteinMorrison ELRRPCSR: Corticotropin and cortisone treatment for systemic lupus erythematosus, J. A. M. A. 149: 995, 1952. CrossrefMedlineGoogle Scholar17. Dubois EL: Prednisone and prednisolone in the treatment of systemic lupus erythematosus, J. A. M. A. 161: 427 (June 2) 1956. CrossrefMedlineGoogle Scholar18. ChasisGoldringBaldwin HWDS: Effect of febrile plasma, typhoid vaccine and nitrogen mustard on renal manifestations of human glomerulonephritis, Proc. Soc. Exper. Biol. and Med. 71: 565, 1949. CrossrefMedlineGoogle Scholar19. DustanCorcoranHaserick HPACJR: Urinary sediment in acute diffuse lupus erythematosus: nature and response to treatment, read before the National Meeting of the American Federation for Clinical Research, Atlantic City, N. J., May, 1951. Google Scholar20. Dubois EL: Nitrogen mustard in treatment of systemic lupus erythematosus, Arch. Int. Med. 93: 667, 1954. CrossrefGoogle Scholar21. JessarLamont-HaversRagan RARWC: Natural history of lupus erythematosus disseminatus, Ann. Int. Med. 38: 717, 1953. LinkGoogle Scholar22. Finney DJ: Probit analysis. A statistical treatment of the sigmoid response curve, 1947, Cambridge University Press, New York. Google Scholar23. ZinkhamConley WHCL: Some factors influencing the formation of L.E. cells, Bull. Johns Hopkins Hosp. 98: 102 (Feb.) 1956. MedlineGoogle Scholar24. Kurnick NB: A rational therapy of systemic lupus erythematosus, Arch. Int. Med. 97: 562 (May) 1956. CrossrefGoogle Scholar25. MullinsWattsWilson JFFLCJ: Plaquenil in the treatment of lupus erythematosus J. A. M. A. 161: 879 (June 30) 1956. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Los Angeles, California*Presented at the Thirty-seventh Annual Session of The American College of Physicians, Los Angeles, California, April 16, 1956.From the Department of Medicine, University of Southern California School of Medicine, and the Los Angeles County General Hospital.The steroids used in this study were generously supplied by Dr. Elmer Alpert, of Merck & Company, Inc.Atabrine and chloroquine were contributed by Dr. J. B. Rice, of Winthrop-Stearns, Inc. Amodiaquin and its placebo were given us by Dr. E. H. Payne, Parke Davis & Company.Requests for reprints should be addressed to Edmund L. Dubois, M.D., Assistant Clinical Professor of Medicine, University of Southern California School of Medicine, Los Angeles, California. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCertain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseasesPrognosis and Mortality of SLEEvaluation of serum uric acid level in systemic lupus erythematosus patients with normal and high pulmonary arterial hypertensionRemission in systemic lupus erythematosus: durable remission is rareRemission in SLE: closing in on the targetProlonged Clinical Remission in Patients with Systemic Lupus ErythematosusMortality in SLESurviving the butterfly and the wolf: mortality trends in systemic lupus erythematosusRisk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosusCelecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLEAntimalarialsANTIMALARIALSSystemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationPatterns of disease activity in systemic lupus erythematosusSystemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation1High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosusImmunosuppressive AgentsHydroxychloroquine: past, present, futureThe efficacy of antimalarials in systemic lupus erythematosusControlled trial with chloroquine diphosphate in systemic lupus erythematosusRemission of Systemic Lupus ErythematosusIMMUNOSUPPRESSIVE DRUG THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUSThe Efficacy of Antimalarials in Systemic Lupus ErythematosusDoes chloroquine cause seizures? Presentation of three new cases and a review of the literatureLupus erythematosus in the 1980s: A survey of 570 patientsA Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusSystemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively.Diabetes Mellitus and Myasthenia Gravis in a Patient with Systemic Onset Juvenile Chronic ArthritisEfficacy of antimalarials in systemic lupus erythematosusTreatmentSteroid receptor antibodies in autoimmune disordersCardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 PatientsCutaneous Complications of Immunosuppressive AgentsPneumococcal epiglottitis in systemic lupus erythematosus on high-dose corticosteroids.Pancreatitis in systemic lupus erythematosusSystemic Lupus Erythematosus: Important considerations in the adolescentAntimalarial Therapy in SLELupus nephritisProlonged complete remission in previously severe SLE.Induction of selective acid hydrolase release from mouse macrophages during exposure to chloroquine and quinineAntimalarials in the management of discoid and systemic lupus erythematosusCardiomyopathy after Chloroquine TreatmentDistribution of an 125I-labelled chloroquine analogue in a pregnant macaca monkeyCryptococcal meningitis in steroid-treated systemic lupus erythematosusChloroquine-Induced Retinal Gangliopathy: A Literature Review and Consideration of its Use as a Screening ProcedureIncidence of infection in systemic lupus erythematosusThe Fourth Component of Complement in the Cerebrospinal Fluid in Systemic Lupus ErythematosusAngiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosusChloroquine-induced depression of neuromuscular transmissionREFERENCESObservations on the short-term effects of chloroquine on skeletal muscleCurare Sensitivity and Myastheniform Symptoms in Patients with Rheumatoid ArthritisGLUCOCORTICOIDS IN THE CONNECTIVE TISSUE DISEASESNephrotisches Syndrom einschließlich renal bedingter ÖdemeLupus NephritisChronic renal diseases and pregnancy: A reviewHYDRALAZINE (APRESOLBNE) LUPUS WITH FATAL RENAL FAILUREDer viscerale Lupus erythematodesSimilarities and Differences in the Roentgen Finding of Joints in Connective Tissue DiseasesEvaluation of the Hyland L.E.-TestPROLONGED HIGH DOSAGE CORTICOSTEROID THERAPY IN DISSEMINATED LUPUS ERYTHEMATOSUSSimilarities and Differences in the Roentgen Finding of Joints in Connective Tissue DiseasesEvaluation of the Hyland L.E.-TestSerum Polysaccharides in the Diagnosis of Systemic Lupus ErythematosusProphylaxis in patients receiving adrenal steroid therapyRelation of Positive L.E.-Cell Preparations to Activity of Lupus Erythematosus and Corticosteroid TherapyLiver Cirrhosis in Patients with a Lupus Erythematosus-like SyndromeAllgemeine Therapie der Haut, einschließlich der Diät-TherapieRHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (THIRTEENTH RHEUMATISM REVIEW)*CHARLEY J. SMYTH, M.D., F.A.C.P., ROGER L. BLACK, M.D., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P.(C), MAX M. MONTGOMERY, M.D., F.A.C.P., HOWARD F. POLLEY, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P., CARLOS F. SACASA, M.D., F.A.C.P., OTTO STEINBROCKER, M.D., HANS WAINE, M.D., GEORGE M. WILSON JR., M.D.Pericardial Effusion, a Manifestation of Systemic Lupus ErythematosusSYSTEMIC LUPUS ERYTHEMATOSUS AFTER "IDIOPATHIC" THROMBOCYTOPENIC PURPURA: A REVIEW. A study of systemic lupus erythematosus occurring after 78 splenectomies for "idiopathic" thrombocytopenic purpura, with a review of the pertinent literature*†YALE RABINOWITZ, M.D., WILLIAM DAMESHEK, F.A.C.P.Myokarditis und weitere MyokardiopathienSystemic lupus erythematosusSTEROID THERAPY IN COLLAGEN DISEASES. *Vergleich morphologischer und serologischer Kriterien bei der Diagnostik des visceralen ErythematodesStudies in pericarditisDermatologyFactors Influencing the Course and Prognosis of Systemic Lupus ErythematosusPROBLEMS IN THE CORTICOSTEROID THERAPY OF RHEUMATIC DISEASE*WILBUR BLECHMAN, M.D., JOHN H. VAUGHAN, M.D.Triamcinolone in the treatment of allergic conditionsSteroid therapy in pulmonary fibrosesTHE SIGNIFICANCE OF THE LUPUS GLOBULIN-NUCLEOPROTEIN REACTION*†GEORGE J. FRIOU, M.D.Observations on the course and treatment of systemic lupus erythematosusTHE CLINICAL FEATURES, PATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUSClinical and histologic spectrum of the nephrotic syndromeVeränderungen des Zentralnervensystems bei Krankheiten und abnormen Pigmentationen der HautThe Manifestations of Collagen Diseases: With Special Reference to Systemic Lupus Erythematosus and Polyarteritis NodosaFAMILIAL HYPERGAMMAGLOBULINÆMIA AND SYSTEMIC LUPUS ERYTHEMATOSUSENDOBRONCHIAL TUBERCULOSIS IN CHILDRENSOME EFFECTS OF HIGH ALTITUDE ON MANMEPACRINE v. CHLOROQUINEThe Way We LimpControl of Systemic Lupus Erythematosus 1 August 1956Volume 45, Issue 2Page: 163-184KeywordsAntimalarialsArthritisBlood cellsChloroquineHospital medicineLupus erythematosusSteroid therapySteroidsToxicologyWhite blood cells ePublished: 1 December 2008 Issue Published: 1 August 1956 Copyright & PermissionsCopyright ©, 1956, by The American College of PhysiciansPDF downloadLoading ...